Eli Lilly and Company announced the successful completion of its acquisition of Dermira, Inc. Lilly completed the acquisition of Dermira through the merger of Bald Eagle Acquisition Corporation with and into Dermira, with Dermira surviving the merger as a wholly-owned subsidiary of Lilly. As of the expiration of the tender offer, 40,926,025 shares of Dermira…